Cerebral Hemorrhage  >>  Activase (alteplase)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
CLEAR IVH, NCT00650858 / 2004-000919-26: Clinical Trial on Treatment of Intraventricular Hemorrhage

Completed
2
52
US, Canada, Europe
tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo), rt-PA, Cathflo, Activase
Johns Hopkins University, FDA Office of Orphan Products Development, Genentech, Inc.
Intraventricular Hemorrhage
08/08
08/08
MISTIE, NCT00224770: Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation

Completed
2
141
US, Canada, Europe
MIS+Cathflo Activase (drug), rtPA, Intraoperative stereotactic CT-Guided Endoscopic Surgery
Daniel Hanley, National Institute of Neurological Disorders and Stroke (NINDS), Genentech, Inc., Emissary International LLC
Intracerebral Hemorrhage
08/12
04/13

Download Options